<DOC>
	<DOCNO>NCT01392300</DOCNO>
	<brief_summary>The purpose study determine whether injection Botulinum toxin type A muscle upper limb effective treating spasticity patient stroke .</brief_summary>
	<brief_title>Efficacy Safety Study Botulinum Toxin Type A Against Placebo Treat Spasticity Arm After Stroke</brief_title>
	<detailed_description>The study consist randomize , double-blind , placebo-controlled , parallel-group , single-dose main period follow open-label , non-controlled , repeated-dose extension period ( Open-Label Extension Period - OLEX ) .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<criteria>Upper limb spasticity Time since stroke great 3 month Need 400 U Botulinum toxin type A Body weight 50kg Fixed contracture upper limb Generalized disorder muscle activity like Myasthenia gravis preclude use Botulinum toxin Type A Infection injection site</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>